Glucokinase, the pancreatic glucose sensor, is not the gut glucose sensor

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Diabetologia

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00125-008-1183-9PMID 18974968
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic Patients

  2008cited by this paper
• Long-Term Follow-Up of Oral Glucose Tolerance Test–Derived Glucose Tolerance and Insulin Secretion and Insulin Sensitivity Indexes in Subjects With Glucokinase Mutations (MODY2)

  2008cited by this paper
• Enteroendocrine cells: a site of ‘taste’ in gastrointestinal chemosensing

  2008cited by this paper
• Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1

  2007cited by this paper
• Engineered enteroendocrine cells secrete insulin in response to glucose and reverse hyperglycemia in diabetic mice.

  2007cited by this paper
• Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell line

  2007cited by this paper
• T1R3 and gustducin in gut sense sugars to regulate expression of Na+-glucose cotransporter 1

  2007cited by this paper
• Impaired β‐cell function in lean normotolerant former gestational diabetic women

  2006cited by this paper
• Impaired beta-cell function in lean normotolerant former gestational diabetic women.

  2006cited by this paper
• Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.

  2006cited by this paper
• Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance.

  2006cited by this paper
• beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.

  2005cited by this paper
• A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line.

  2003cited by this paper
• BETA2 activates transcription from the upstream glucokinase gene promoter in islet beta-cells and gut endocrine cells.

  2003cited by this paper
• Glucose-sensing in glucagon-like peptide-1-secreting cells.

  2002cited by this paper
• Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation.

  2002cited by this paper
• The genetic abnormality in the beta cell determines the response to an oral glucose load

  2002cited by this paper
• Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects.

  2002cited by this paper
• Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus.

  2001cited by this paper
• Glucose-dependent insulin release from genetically engineered K cells.

  2000cited by this paper
• Counterregulatory responses to hypoglycemia in patients with glucokinase gene mutations.

  2000cited by this paper
• Identification and Characterization of Glucoresponsive Neurons in the Enteric Nervous System

  1999cited by this paper
• Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program

  1998cited by this paper
• Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects.

  1996cited by this paper
• Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig.

  1996cited by this paper
• The 30 Minute Insulin Incremental Response in an Oral Glucose Tolerance Test as a Measure of Insulin Secretion

  1995cited by this paper
• Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations.

  1994cited by this paper
• Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut.

  1994cited by this paper
• Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans

  1994cited by this paper
• Differentiating Glucose Toxicity From Glucose Desensitization: A New Message From the Insulin Gene

  1994cited by this paper
• Glucokinase as pancreatic beta cell glucose sensor and diabetes gene.

  1993cited by this paper
• Glucose Toxicity

  1990cited by this paper
• Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy.

  1988cited by this paper
• Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses.

  1986cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics.

  1983cited by this paper

• Emerging Role of Taste Receptors, Entero-Endocrine Cells in Type 2 Diabetes and Metabolic Disorders

  2026cites this paper
• Safety profile of glucokinase activator AZD1656: systematic review and meta-analysis of 23 randomised trials in diabetic and healthy volunteers with relevance to immunomodulatory therapy

  2025cites this paper
• Unraveling the impaired incretin effect in obesity and type 2 diabetes: Key role of hyperglycemia-induced unscheduled glycolysis and glycolytic overload.

  2024cites this paper
• Should Glucokinase be Given a Chance in Diabetes Therapeutics? A Clinical-Pharmacological Review of Dorzagliatin and Lessons Learned So Far

  2024cites this paper
• Glucokinase activators and imeglimin: new weaponry in the armamentarium against type 2 diabetes

  2024cites this paper
• Nutrient sensors and their crosstalk

  2023cites this paper
• A phase I open-label clinical trial to study drug-drug interactions of Dorzagliatin and Sitagliptin in patients with type 2 diabetes and obesity

  2023cites this paper
• review on upregulation of glucokinase expression by selected plants and their phytoconstituents

  2022cites this paper
• Nutrient-Induced Cellular Mechanisms of Gut Hormone Secretion

  2021cites this paper
• Clinical implications of the glucokinase impaired function - GCK MODY today.

  2020cites this paper
• Glucokinase activation as antidiabetic therapy: effect of nutraceuticals and phytochemicals on glucokinase gene expression and enzymatic activity

  2019cites this paper
• Hyperlipidemias and Obesity

  2019cites this paper
• Distribution and Stimulus Secretion Coupling of Enteroendocrine Cells along the Intestinal Tract.

  2018cites this paper
• Enteroendocrine Cells: Chemosensors in the Intestinal Epithelium.

  2016cites this paper
• Carbohydrate‐induced secretion of glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1

  2016cites this paper
• Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young.

  2015cites this paper
• An Absorbing Sense of Sweetness

  2015cites this paper
• A patent review of glucokinase activators and disruptors of the glucokinase – glucokinase regulatory protein interaction: 2011 – 2014

  2014cites this paper
• Molecular Mechanisms of Glucose-Stimulated GLP-1 Secretion From Perfused Rat Small Intestine

  2014cites this paper
• Evolution- and Structure-Based Computational Strategy Reveals the Impact of Deleterious Missense Mutations on MODY 2 (Maturity-Onset Diabetes of the Young, Type 2)

  2014cites this paper
• PI3K-AKT-mTOR-Signaling and beyond: the Complex Network in Gastroenteropancreatic Neuroendocrine Neoplasms

  2014cites this paper
• Incretin Effect and Glucagon Responses to Oral and Intravenous Glucose in Patients With Maturity-Onset Diabetes of the Young—Type 2 and Type 3

  2014cites this paper
• Familial adult onset hyperinsulinism due to an activating glucokinase mutation: implications for pharmacological glucokinase activation

  2014cites this paper
• Pathogenesis of the Metabolic Syndrome: Insights from Monogenic Disorders

  2013cites this paper
• Monogenic Diabetes: A Diagnostic Algorithm for Clinicians

  2013cites this paper
• Strategies for the design of hepatoselective glucokinase activators to treat type 2 diabetes

  2013cites this paper
• The effects of incretins on energy homeostasis: physiology and implications for the treatment of type 2 diabetes mellitus and obesity.

  2012cites this paper
• Intestinal sensing of nutrients.

  2012cites this paper
• Safety, pharmacokinetics and pharmacodynamics of multiple‐ascending doses of the novel glucokinase activator AZD1656 in patients with type 2 diabetes mellitus

  2012cites this paper
• Novel Enteroendocrine Cell Receptors Regulating Incretin Secretion and Glucose Homeostasis

  2012cites this paper
• Gut induced biomarkers of appetite and satiety

  2012cites this paper
• Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus.

  2012cites this paper
• Appetite Control

  2012cites this paper
• Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects.

  2011cites this paper
• The heritability of beta cell function parameters in a mixed meal test design

  2011cites this paper
• Glucose and fructose as functional modulators of overall dog, but not boar sperm function.

  2011cites this paper
• Gut as an Endocrine Organ: The Role of Nutrient Sensing in Energy Metabolism

  2011cites this paper
• Characterization of protein and peptide sensing processes in the gut coupled to gastrointestinal hormone secretion using ex-vivo models

  2011influential citation
• GDAŃSKI UNIWERSYTET MEDYCZNY

  2010cites this paper
• The role of amniotic fluid in influencing neonatal birth weight

  2010cites this paper
• Molecular mechanisms underlying nutrient-stimulated incretin secretion

  2010cites this paper
• Synergistic contributions of fullerene, ferrocene, chitosan and ionic liquid towards improved performance for a glucose sensor.

  2010cites this paper
• Molecular mechanisms underlying nutrient detection by incretin-secreting cells

  2010cites this paper
• The heritability of meal related-cell function Chapter 4 The heritability of-cell function parameters in a mixed meal test design

  2010cites this paper
• The Effect of Insulin and Insulin Resistance on Glucagon-like Peptide-1 Secretion from the Intestinal L Cell

  2010cites this paper
• Clinical and pathomorphological characterisation of two diabetic mouse models derived from the Munich ENU mouse mutagenesis project

  2010cites this paper
• GDAŃSKI UNIWERSYTET MEDYCZNY

  2009cites this paper
• Assessing the potential of glucokinase activators in diabetes therapy

  2009cites this paper
• Incretin release from gut is acutely enhanced by sugar but not by sweeteners in vivo.

  2009cites this paper
• Update on mutations in glucokinase (GCK), which cause maturity‐onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia

  2009cites this paper
• Current literature in diabetes

  2009cites this paper